V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031105 | 20013274 | null | null | Neo-adjuvant (N) | 2016-08-23 | 2016-09-05 | FEC 100 + DOCETAXEL | N | N | 20109466 | FEC + DOCETAXEL |
| 20031106 | 20013274 | 1.51 | 79.45 | Adjuvant (A) | 2017-09-14 | 2017-09-21 | FEC + DOCETAXEL | N | N | 20109466 | FEC + DOCETAXEL |
| 20031107 | 20013275 | 1.43 | 72 | Not known (9) | 2013-07-17 | 2013-07-17 | FEC + DOCETAXEL | N | N | 20109478 | FEC + DOCETAXEL |
| 20031108 | 20013275 | 1.55 | null | null | 2013-12-07 | 2013-12-13 | FEC 100 + DOCETAXEL | N | N | 20109478 | FEC + DOCETAXEL |
| 20031109 | 20013275 | null | null | Adjuvant (A) | 2017-10-22 | 2017-10-23 | FEC + DOCETAXEL | N | N | 20109478 | FEC + DOCETAXEL |
| 20031110 | 20013276 | 1.62 | 87 | Adjuvant (A) | 2017-01-22 | 2017-01-22 | FEC 60 OR 75 + DOCETAXEL | 2 | N | 20109484 | FEC + DOCETAXEL |
| 20031111 | 20013276 | 1.69 | 70 | Curative (C) | 2015-03-05 | 2015-03-18 | FEC 100 + DOCETAXEL | 2 | Y | 20109484 | FEC + DOCETAXEL |
| 20031112 | 20013277 | null | null | Adjuvant (A) | null | 2013-12-04 | FEC + DOCETAXEL | null | null | 20109496 | FEC + DOCETAXEL |
| 20031113 | 20013277 | null | null | Adjuvant (A) | 2017-10-05 | 2017-10-19 | FEC + DOCETAXEL | null | N | 20109496 | FEC + DOCETAXEL |
| 20031114 | 20013278 | 1.58 | 66 | Neo-adjuvant (N) | 2015-10-16 | 2015-10-16 | FEC + DOCETAXEL | 02 | null | 20109498 | FEC + DOCETAXEL |
| 20031115 | 20013279 | 1.73 | 115 | Adjuvant (A) | 2016-01-18 | 2016-01-18 | FEC 100 + DOCETAXEL | N | N | 20109499 | FEC + DOCETAXEL |
| 20031116 | 20013279 | 1.55 | 89.2 | Adjuvant (A) | 2014-01-27 | 2014-02-13 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20109499 | FEC + DOCETAXEL |
| 20031117 | 20013279 | null | null | Neo-adjuvant (N) | 2013-10-19 | 2013-11-08 | FEC 100 + DOCETAXEL | N | N | 20109499 | FEC + DOCETAXEL |
| 20031118 | 20013280 | 1.7 | 54 | Adjuvant (A) | 2013-03-07 | 2013-04-10 | FEC + DOCETAXEL | 02 | N | 20109504 | FEC + DOCETAXEL |
| 20031119 | 20013280 | 1.68 | 63.6 | Adjuvant (A) | null | 2016-03-17 | FEC + DOCETAXEL | N | N | 20109504 | FEC + DOCETAXEL |
| 20031120 | 20013280 | null | 105.4 | Adjuvant (A) | 2017-12-16 | 2018-01-12 | FEC 100 + DOCETAXEL | 2 | N | 20109504 | FEC + DOCETAXEL |
| 20031121 | 20013281 | null | null | Adjuvant (A) | 2014-07-05 | 2014-08-04 | FEC + DOCETAXEL | N | N | 20109518 | FEC + DOCETAXEL |
| 20031122 | 20013281 | null | 53.6 | Adjuvant (A) | 2015-09-07 | 2015-09-13 | FEC 100 + DOCETAXEL | 2 | N | 20109518 | FEC + DOCETAXEL |
| 20031123 | 20013282 | 1.63 | 74 | null | 2015-05-14 | 2015-05-30 | FEC 100 + DOCETAXEL | null | N | 20109531 | FEC + DOCETAXEL |
| 20031124 | 20013283 | null | 58.2 | Adjuvant (A) | 2013-03-12 | 2013-04-01 | FEC + DOCETAXEL | 02 | N | 20109532 | FEC + DOCETAXEL |
| 20031125 | 20013283 | 1.59 | 69 | Neo-adjuvant (N) | 2017-08-23 | 2017-08-25 | FEC 100 + DOCETAXEL | N | N | 20109532 | FEC + DOCETAXEL |
| 20031126 | 20013284 | 1.65 | 91 | Neo-adjuvant (N) | 2014-12-11 | 2014-12-23 | FEC 100 + DOCETAXEL | N | N | 20109542 | FEC + DOCETAXEL |
| 20031127 | 20013285 | 1.68 | 48.2 | Not known (9) | null | 2016-07-23 | FEC + DOCETAXEL | N | N | 20109544 | FEC + DOCETAXEL |
| 20031128 | 20013286 | null | 76 | Adjuvant (A) | 2014-02-04 | 2014-02-15 | FEC 100 + DOCETAXEL | N | N | 20109545 | FEC + DOCETAXEL |
| 20031129 | 20013286 | 1.61 | 85 | Not known (9) | 2017-04-29 | 2017-04-30 | FEC + DOCETAXEL | 02 | N | 20109545 | FEC + DOCETAXEL |
| 20031130 | 20013287 | 1.6 | 65.7 | Adjuvant (A) | 2015-05-17 | 2015-06-05 | FEC + DOCETAXEL | 02 | N | 20109553 | FEC + DOCETAXEL |
| 20031131 | 20013288 | null | 76.9 | Adjuvant (A) | 2014-05-10 | 2014-05-10 | FEC + DOCETAXEL | 02 | N | 20109555 | FEC + DOCETAXEL |
| 20031132 | 20013288 | 1.65 | 57 | Adjuvant (A) | 2016-09-29 | 2016-10-12 | FEC + DOCETAXEL | 02 | N | 20109555 | FEC + DOCETAXEL |
| 20031133 | 20013288 | 1.63 | 95.45 | Not known (9) | 2014-03-16 | 2014-04-02 | FEC + DOCETAXEL | N | N | 20109555 | FEC + DOCETAXEL |
| 20031134 | 20013289 | 1.65 | 66 | Neo-adjuvant (N) | 2016-06-18 | 2016-06-19 | FEC + DOCETAXEL | 02 | Y | 20109569 | FEC + DOCETAXEL |
| 20031135 | 20013289 | 1.62 | 75 | Adjuvant (A) | null | 2017-08-05 | FEC + DOCETAXEL | N | N | 20109569 | FEC + DOCETAXEL |
| 20031136 | 20013290 | 1.62 | 63 | Adjuvant (A) | 2013-11-24 | 2013-12-08 | FEC + DOCETAXEL | N | null | 20109582 | FEC + DOCETAXEL |
| 20031137 | 20013290 | null | null | Adjuvant (A) | 2013-12-09 | 2013-12-24 | FEC + DOCETAXEL | N | N | 20109582 | FEC + DOCETAXEL |
| 20031138 | 20013290 | 1.69 | 82 | Neo-adjuvant (N) | null | 2016-03-25 | FEC + DOCETAXEL | N | N | 20109582 | FEC + DOCETAXEL |
| 20031139 | 20013290 | 1.58 | 57.8 | Adjuvant (A) | 2014-06-20 | 2014-07-02 | FEC + DOCETAXEL | N | N | 20109582 | FEC + DOCETAXEL |
| 20031140 | 20013290 | 1.73 | 64 | Adjuvant (A) | 2016-03-25 | 2016-03-25 | FEC 100 + DOCETAXEL | 02 | Y | 20109582 | FEC + DOCETAXEL |
| 20031141 | 20013290 | null | 105 | Adjuvant (A) | 2013-04-09 | 2013-04-15 | FEC + DOCETAXEL | 02 | N | 20109582 | FEC + DOCETAXEL |
| 20031142 | 20013290 | null | null | Adjuvant (A) | 2017-07-23 | 2017-08-19 | FEC 100 + DOCETAXEL | 2 | N | 20109582 | FEC + DOCETAXEL |
| 20031143 | 20013291 | 1.65 | 77.9 | Curative (C) | 2018-03-01 | 2018-03-01 | FEC 100 + DOCETAXEL | 02 | N | 20109605 | FEC + DOCETAXEL |
| 20031144 | 20013291 | 1.59 | 79 | Adjuvant (A) | 2015-03-24 | 2015-03-27 | FEC + DOCETAXEL | 2 | N | 20109605 | FEC + DOCETAXEL |
| 20031145 | 20013291 | 1.63 | 77 | Adjuvant (A) | 2017-08-08 | 2017-08-10 | FEC + DOCETAXEL | 02 | N | 20109605 | FEC + DOCETAXEL |
| 20031146 | 20128178 | 1.64 | 14 | Adjuvant (A) | 2017-07-31 | 2017-08-21 | FEC + DOCETAXEL | N | null | 20109619 | FEC + DOCETAXEL |
| 20031147 | 20013292 | 1.63 | 93 | Adjuvant (A) | 2015-12-05 | 2015-12-05 | FEC + DOCETAXEL | 2 | N | 20109621 | FEC + DOCETAXEL |
| 20031148 | 20013293 | 1.59 | 70.8 | Neo-adjuvant (N) | 2017-04-27 | 2017-05-11 | FEC + DOCETAXEL | N | N | 20109623 | FEC + DOCETAXEL |
| 20031149 | 20013294 | 1.67 | 66.6 | Adjuvant (A) | 2015-07-28 | 2015-08-11 | FEC + DOCETAXEL | N | N | 20109624 | FEC + DOCETAXEL |
| 20031150 | 20013294 | 1.63 | 63.3 | Palliative (P) | 2014-06-01 | 2014-06-02 | FEC + DOCETAXEL | N | N | 20109624 | FEC + DOCETAXEL |
| 20031151 | 20013295 | 1.65 | 66 | Neo-adjuvant (N) | 2013-10-09 | 2013-10-17 | FEC + DOCETAXEL | 02 | N | 20109627 | FEC + DOCETAXEL |
| 20031152 | 20013295 | 1.55 | 78 | Adjuvant (A) | null | 2017-02-22 | FEC 100 + DOCETAXEL | N | N | 20109627 | FEC + DOCETAXEL |
| 20031153 | 20013296 | 1.6 | 75 | Adjuvant (A) | 2015-04-11 | 2015-04-15 | FEC + DOCETAXEL | 02 | N | 20109633 | FEC + DOCETAXEL |
| 20031154 | 20013296 | 1.67 | 58.6 | Adjuvant (A) | 2016-01-15 | 2016-01-18 | FEC + DOCETAXEL | 02 | N | 20109633 | FEC + DOCETAXEL |